Show simple item record

dc.contributor.authorGranado Casas, Minerva
dc.contributor.authorCastelblanco Echavarría, Esmeralda
dc.contributor.authorRamírez-Morros, Anna
dc.contributor.authorMartín, Mariona
dc.contributor.authorAlcubierre Calvo, Núria
dc.contributor.authorMartínez Alonso, Montserrat
dc.contributor.authorValldeperas, Xavier
dc.contributor.authorTraveset Maeso, Alicia
dc.contributor.authorRubinat, Esther
dc.contributor.authorLucas-Martin, Ana
dc.contributor.authorHernández, Marta
dc.contributor.authorAlonso, Núria
dc.contributor.authorMauricio Puente, Dídac
dc.date.accessioned2019-11-04T09:03:50Z
dc.date.available2019-11-04T09:03:50Z
dc.date.issued2019-03-18
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/10459.1/67443
dc.description.abstractDiabetic retinopathy (DR) may potentially cause vision loss and affect the patient's quality of life (QoL) and treatment satisfaction (TS). Using specific tools, we aimed to assess the impact of DR and clinical factors on the QoL and TS in patients with type 1 diabetes. This was a cross-sectional, two-centre study. A sample of 102 patients with DR and 140 non-DR patients were compared. The Audit of Diabetes-Dependent Quality of Life (ADDQoL-19) and Diabetes Treatment Satisfaction Questionnaire (DTSQ-s) were administered. Data analysis included bivariate and multivariable analysis. Patients with DR showed a poorer perception of present QoL (p = 0.039), work life (p = 0.037), dependence (p = 0.010), and had a lower average weighted impact (AWI) score (p = 0.045). The multivariable analysis showed that DR was associated with a lower present QoL (p = 0.040), work life (p = 0.036) and dependence (p = 0.016). With regards to TS, DR was associated with a higher perceived frequency of hypoglycaemia (p = 0.019). In patients with type 1 diabetes, the presence of DR is associated with a poorer perception of their QoL. With regard to TS, these subjects also show a higher perceived frequency of hypoglycaemia.
dc.description.sponsorshipThis study was supported by the Catalan Diabetes Association (Beca d’Educació Terapèutica 2015), Spain. Additional support from grants PI12/00183 and PI15/00625 from the Instituto de Salud Carlos III (Ministry of Economy and Competitiveness, Spain) to DM is acknowledged. CIBERDEM is an initiative from the Instituto de Salud Carlos III (Plan Nacional de I + D + I and Fondo Europeo de Desarrollo Regional). M.G.-C. holds a predoctoral fellowship from the Ministerio de Educación, Cultura y Deporte, FPU15/03005.
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a https://doi.org/10.3390/jcm8030377
dc.relation.ispartofJournal of Clinical Medicine, 2019, vol. 8, num. 3
dc.rightscc-by (c) Granado et al., 2019
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectDiabetic retinopathy
dc.subjectType 1 diabetes
dc.subjectQuality of life
dc.subjectTreatment satisfaction
dc.subjectPatient-reported outcomes
dc.titlePoorer Quality of Life and Treatment Satisfaction is Associated with Diabetic Retinopathy in Patients with Type 1 Diabetes without Other Advanced Late Complications
dc.typeinfo:eu-repo/semantics/article
dc.date.updated2019-11-04T09:03:55Z
dc.identifier.idgrec029056
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.identifier.doihttps://doi.org/10.3390/jcm8030377


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

cc-by (c) Granado et al., 2019
Except where otherwise noted, this item's license is described as cc-by (c) Granado et al., 2019